对羟基苯乙酮对正常大鼠胆汁分泌及高脂血症的影响

邓轶方; 于鹏霞; 黄晓玲; 贺兴冬; 殷明; 刘珉宇

doi:10.3969/j.issn.1006-0111.2016.06.007

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

重要提示

《药学实践与服务》杂志不接收生物战剂、毒剂相关内容的稿件。对于涉军信息类论文如需投稿，请务必投稿前电话或邮箱咨询。联系电话：021-81871323，邮箱：yxsjzzs@163.com。敬请谅解，谢谢配合！

《药学实践与服务》编辑部

重要通知

《药学实践与服务》杂志目前不收取审稿费、版面费、加急费等费用，如收到邮件声称是编辑部X编辑，要求加作者微信的，或填写编委登记申请表的，请谨防诈骗！

编辑部用于作者校稿时微信绑定的邮件是通过官方邮箱：yxsjzzs@163.com发送的，标题是《药学实践与服务》XML数字出版服务微信绑定，请区分开！如有疑虑，请联系编辑部，电话：021-81871323。

《药学实践与服务》编辑部

对羟基苯乙酮对正常大鼠胆汁分泌及高脂血症的影响

邓轶方, 于鹏霞, 黄晓玲, 贺兴冬, 殷明, 刘珉宇

文章导航 > 药学实践与服务 > 2016 > 34(6): 507-510,525

邓轶方, 于鹏霞, 黄晓玲, 贺兴冬, 殷明, 刘珉宇. 对羟基苯乙酮对正常大鼠胆汁分泌及高脂血症的影响[J]. 药学实践与服务, 2016, 34(6): 507-510,525. doi: 10.3969/j.issn.1006-0111.2016.06.007

引用本文:

DENG Yifang, YU Pengxia, HUANG Xiaoling, HE Xingdong, YIN Ming, LIU Minyu. Effects of p-hydroxyacetophenone on bile secretion and blood lipid levels in rats[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(6): 507-510,525. doi: 10.3969/j.issn.1006-0111.2016.06.007

Citation:

DENG Yifang, YU Pengxia, HUANG Xiaoling, HE Xingdong, YIN Ming, LIU Minyu. Effects of p-hydroxyacetophenone on bile secretion and blood lipid levels in rats[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(6): 507-510,525. doi: 10.3969/j.issn.1006-0111.2016.06.007

对羟基苯乙酮对正常大鼠胆汁分泌及高脂血症的影响

doi: 10.3969/j.issn.1006-0111.2016.06.007

1.
中国医药工业研究总院, 上海 201203
2.
上海交通大学药学院, 上海 200240

Effects of p-hydroxyacetophenone on bile secretion and blood lipid levels in rats

1.
China State Institute of Pharmaceutical Industry, Shanghai 201203 China
2.
School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China

摘要: 目的研究对羟基苯乙酮（PHA）促胆汁分泌和降血脂作用以及初步作用机制。方法正常SD大鼠行胆管插管术，收集给药前30 min和给药后3 h分泌的胆汁，测定胆汁单位时间内的分泌量和胆汁成分；建立大鼠高血脂模型，观察PHA的降胆固醇作用；制备正常大鼠可溶性HMG-CoA还原酶，测定PHA对HMG-CoA还原酶活性的影响；对大鼠高胆固醇血症实验中得到的动物肝脏样本，进行Real-time PCR试验。结果 PHA可以增加实验大鼠胆汁和胆汁酸的分泌量；同时能够显著降低高胆固醇血症大鼠的胆固醇水平，具有调血脂作用；初步的作用机制研究显示，PHA抑制HMG-CoA还原酶活性的作用较弱，但可以促进影响胆汁酸外排及胆固醇转化的AQP8、CYP7A1、OATP、NTCP等基因的转录。结论 PHA作为茵陈中一种有效的单体化合物，可用于促进胆汁分泌、调节血脂代谢药物的研发。
- 对羟基苯乙酮 /
- 茵陈 /
- 利胆 /
- 胆固醇
Abstract: Objective To study the effects and mechanism of p-hydroxyacetophenone (PHA) on bile secretion, cholesterol metabolism and blood lipids. Methods Cystic duct cannula was cannulated and bile were collected in SD rats.PHA was administrated in the high cholesterol rats. The activity of HMG-CoA reductase was determined by spectrophotometry in reaction system. Samples of liver were obtained in experiment hypercholesterolemia rats and Real-time PCR test was conducted for AQP8, CYP7A1, OATP and NTCP. Results Secretion of bile were increased, cholesterol in bile were reduced and secretion of total bile acid were increased in rats by PHA. The level of serum cholesterol in hyperglycemia rat model was reduced significantly and inhibitory ability had been limited in the activity of HMG-CoA reeducates by PHA, but the gene transcription including AQP8, CYP7A1, OATP, and NTCP were promoted, which are related to function of excretion of biliary acid and transformation of cholesterol. Conclusion These results suggest that PHA, as a lead compound, might be of significance for further development for a bile secretory and lipid lowering agent.
- p-hydroxyacetophenone(PHA) /
- artemisiae capillaries /
- choleretic /
- cholesterol

[1]	胡熙明,张文康,朱庆生,等.中华本草(第7册)[M].上海:上海科学技术出版社,1999:687-693.
[2]	谢韬, 梁敬钰, 刘净. 茵陈化学成分和药理作用研究进展[J]. 海峡药学, 2004, 16(1):8-13.
[3]	曹锦花.茵陈的化学成分和药理作用研究进展[J].沈阳药科大学学报,2013,30(6):489-494.
[4]	董岩,王新芳,崔长军,等. 茵陈蒿的化学成分和药理作用研究进展[J]. 时珍国医国药, 2008, 19(04):874-876.
[5]	Yoon M,Kim MY.The anti-angiogenic herbal composition Ob-X from Morus alba,Melissa officinalis, and Artemisia capillaris regulates obesity in genetically obese ob/ob mice[J]. Pham Biol,2011,49(6):614-619.
[6]	向怀,覃薛文.茵陈清热利胆汤治疗妊娠期肝内胆汁淤积症30例总结[J].湖南中医杂志,2013,29(6):49-50.
[7]	张林丽. 茵陈的药理研究和临床应用近况[J]. 广西医学,2003, 25(11):2184-2185.
[8]	李佳佳,罗贞恋,覃川,等.茵陈蒿汤加味方对高脂血症小鼠血清总胆固醇和甘油三酯影响的实验研究[J].贵阳中医学院学报, 2014, 36(6):24-27.
[9]	Richard A J, Fuller S, Fedocenco V, et al. Artemisia scoparia enhances adipocyte development and endocrine function in vitro and enhances insulin action in vivo[J]. PLoS ONE,2014, 9(6):e98897.
[10]	王喜军,李廷利,孙晖.茵陈蒿汤及其血中移行成分6,7二甲氧基香豆素的肝保护作用[J].中国药理学通报,2004,20(2):239-240.
[11]	阙金花,黄鸣清,郑海音,等. 复方熊胆茵陈颗粒的保肝、降血脂、抗脂肪肝药效学研究[J]. 中国医院药学杂志, 2015,35(19):1736-1740.
[12]	Wang Z Q, Zhang X, Yu Y, et al. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway[J].Metab Clin Exp, 2013, 62(9):1239-1249.

[1]	郭羽晨, 李骏驰, 杨国苓, 章越凡, 李铁军, 孙莉莉. 青黛对脑缺血再灌注损伤小鼠的保护作用研究 . 药学实践与服务, 2026, 44(): 1-8. doi: 10.12206/j.issn.2097-2024.202510044
[2]	李倩, 王荣, 杨峰, 王晓锋, 尹东锋. 高原低氧对药物代谢的影响及机制研究进展 . 药学实践与服务, 2026, 44(6): 275-279. doi: 10.12206/j.issn.2097-2024.202403018
[3]	林玉茹, 胡巧灵, 王欣荣, 鲁仁义, 王彦, 陈莉. 病原真菌对药物高适应性的研究进展 . 药学实践与服务, 2026, 44(4): 178-184. doi: 10.12206/j.issn.2097-2024.202510030
[4]	乔方良, 蒋益萍, 夏天爽, 刘爱军, 赵凯, 辛海量. 对萼猕猴桃苷E提取分离纯化工艺的研究 . 药学实践与服务, 2026, 44(3): 137-143. doi: 10.12206/j.issn.2097-2024.202407001
[5]	胡文宇, 史文俊, 王学武, 李硕硕. 金线莲苷对小鼠酒精性肝损伤的作用机制研究 . 药学实践与服务, 2026, 44(1): 12-19. doi: 10.12206/j.issn.2097-2024.202309030
[6]	葛鹏程, 苏日古嘎, 任天舒, 党大胜. 硫酸黏菌素联合头孢哌酮舒巴坦治疗泛耐药鲍曼不动杆菌肺内感染的疗效分析 . 药学实践与服务, 2026, 44(5): 264-267. doi: 10.12206/j.issn.2097-2024.202404093
[7]	韩丹, 于飞, 朱昕桐, 武玥, 邵尉, 李睿旻. 医保情景下利司扑兰治疗儿童脊髓性肌萎缩症的经济学评价 . 药学实践与服务, 2026, 44(8): 431-436. doi: 10.12206/j.issn.2097-2024.202601017
[8]	张婷艳, 李婷婷, 袁晓凤, 张川, 郝锴, 卞俊. 基于网络药理学和分子对接技术探讨丹参酮ⅡA改善对乙酰氨基酚致肝损伤的作用机制 . 药学实践与服务, 2026, 44(8): 1-9. doi: 10.12206/j.issn.2097-2024.202412022
[9]	孟盼盼, 宋慕格, 杨世超, 陈克明, 杨中铎, 马慧萍. 基于Keap1/Nrf2/HO-1信号通路研究利舒康胶囊对高原缺氧小鼠学习记忆障碍的改善作用 . 药学实践与服务, 2026, 44(1): 26-31, 52. doi: 10.12206/j.issn.2097-2024.202303006
[10]	张霖峰, 孙宇恒, 王冬尧, 李丹, 曹岩, 吕狄亚. 茵陈蒿汤体内成分分析及其抗肝癌作用机制的网络药理学研究 . 药学实践与服务, 2026, 44(4): 200-208. doi: 10.12206/j.issn.2097-2024.202501017
[11]	邵明聪, 陈虎博, 张懿丹, 李梓嫣, 王丽娜. 乌头煎剂对小鼠RAW264.7巨噬细胞活性和极化的影响 . 药学实践与服务, 2025, 43(7): 329-334. doi: 10.12206/j.issn.2097-2024.202505043
[12]	魏雨辰, 田家盛, 王道鑫, 凌期盛, 王治, 缪朝玉. 烟酰胺单核苷酸口服给药对高血压大鼠的影响 . 药学实践与服务, 2025, 43(5): 213-221. doi: 10.12206/j.issn.2097-2024.202412006
[13]	詹济华, 颜滢. 低蛋白血症对头孢哌酮舒巴坦血药浓度的影响 . 药学实践与服务, 2025, 43(7): 344-347. doi: 10.12206/j.issn.2097-2024.202309040
[14]	孟园园, 吴芸杨, 陈婷如, 顾秦五风, 杨延龙. 九味永安颗粒联合西替利嗪治疗湿疹湿热蕴肤证的临床疗效观察 . 药学实践与服务, 2025, 43(6): 298-302. doi: 10.12206/j.issn.2097-2024.202407045
[15]	张修平, 田家盛, 王道鑫, 李佳鑫, 王品, 缪朝玉. MT-1207对小鼠血糖、血脂和动脉粥样硬化的作用 . 药学实践与服务, 2024, 42(11): 487-494. doi: 10.12206/j.issn.2097-2024.202306011
[16]	李清, 郭宜银, 陈颖, 瞿发林, 董文燊, 戈煜. 夜宁胶囊对小鼠镇静催眠作用及其机制的研究 . 药学实践与服务, 2024, 42(8): 346-349. doi: 10.12206/j.issn.2097-2024.202211047
[17]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[18]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[19]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[20]	刘依秦, 王超群, 邱娇娜. 胆宁片预处理在糖尿病患者结肠镜检查前的应用效果分析 . 药学实践与服务, 2024, 42(9): 407-410. doi: 10.12206/j.issn.2097-2024.202407037

点击查看大图

计量

文章访问数: 5270
HTML全文浏览量: 649
PDF下载量: 779
被引次数: 0

对羟基苯乙酮对正常大鼠胆汁分泌及高脂血症的影响

doi: 10.3969/j.issn.1006-0111.2016.06.007

1. 中国医药工业研究总院, 上海 201203

2. 上海交通大学药学院, 上海 200240

收稿日期: 2015-12-28
修回日期: 2016-05-30

关键词:

对羟基苯乙酮 /

茵陈 /

利胆 /

胆固醇

摘要: 目的研究对羟基苯乙酮（PHA）促胆汁分泌和降血脂作用以及初步作用机制。方法正常SD大鼠行胆管插管术，收集给药前30 min和给药后3 h分泌的胆汁，测定胆汁单位时间内的分泌量和胆汁成分；建立大鼠高血脂模型，观察PHA的降胆固醇作用；制备正常大鼠可溶性HMG-CoA还原酶，测定PHA对HMG-CoA还原酶活性的影响；对大鼠高胆固醇血症实验中得到的动物肝脏样本，进行Real-time PCR试验。结果 PHA可以增加实验大鼠胆汁和胆汁酸的分泌量；同时能够显著降低高胆固醇血症大鼠的胆固醇水平，具有调血脂作用；初步的作用机制研究显示，PHA抑制HMG-CoA还原酶活性的作用较弱，但可以促进影响胆汁酸外排及胆固醇转化的AQP8、CYP7A1、OATP、NTCP等基因的转录。结论 PHA作为茵陈中一种有效的单体化合物，可用于促进胆汁分泌、调节血脂代谢药物的研发。

English Abstract

Effects of p-hydroxyacetophenone on bile secretion and blood lipid levels in rats

1. China State Institute of Pharmaceutical Industry, Shanghai 201203 China

2. School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China

Received Date: 2015-12-28
Rev Recd Date: 2016-05-30

Keywords:

Abstract: Objective To study the effects and mechanism of p-hydroxyacetophenone (PHA) on bile secretion, cholesterol metabolism and blood lipids. Methods Cystic duct cannula was cannulated and bile were collected in SD rats.PHA was administrated in the high cholesterol rats. The activity of HMG-CoA reductase was determined by spectrophotometry in reaction system. Samples of liver were obtained in experiment hypercholesterolemia rats and Real-time PCR test was conducted for AQP8, CYP7A1, OATP and NTCP. Results Secretion of bile were increased, cholesterol in bile were reduced and secretion of total bile acid were increased in rats by PHA. The level of serum cholesterol in hyperglycemia rat model was reduced significantly and inhibitory ability had been limited in the activity of HMG-CoA reeducates by PHA, but the gene transcription including AQP8, CYP7A1, OATP, and NTCP were promoted, which are related to function of excretion of biliary acid and transformation of cholesterol. Conclusion These results suggest that PHA, as a lead compound, might be of significance for further development for a bile secretory and lipid lowering agent.

引用本文: